李曄雄，博士，籍貫湖南，腫瘤放療專家。中國醫學科學院協和醫科大學腫瘤醫院教授、主任醫師，博士生導師。1984年湖南醫科大學醫療系畢業獲得學士學位，1990年獲中國協和醫科大學放射腫瘤學碩士學位，1997年獲瑞士洛桑大學放射腫瘤學博士學位，1998年在美國德克薩斯大學M.D. Anderson癌癥中心從事博士后研究。2003年起聘任正高，2020年為協和長聘教授。2000年任科主任。一直從事放射腫瘤學臨床和轉化研究。

主要研究領域為惡性腫瘤的放療，開展和應用最先進放療技術，改進治療方法，著重探索淋巴瘤臨床病理和生物學特征，建立風險分層治療原則和放療指南，建立乳腺癌術后短療程大分割照射方案等，居國際領先水平。

久久综合九色欧美综合狠狠_伊人热热久久原色播放WWW_成A人片亚洲日本久久_久久不见久久见免费影院www日本_97久久精品人人做人人爽,又色又爽又黄的视频在线观看,狼群影院视频在线观看高清版,亚洲AV无码精品网站性色,国产乱码久久久久久红粉影视,精品国产乱码久久久久久一区二区,国产精品免费视频网站,国产A级毛片久久久久久精品,一级特黄高清aaaa大片,亚洲中文字幕欧美一区,久久精品国产99久久狂热,黑人巨大精品欧美_黑人巨大精品欧美黑寡妇_黑人巨大精品欧美一区二区_黑人巨大精品欧美一区二区免费_黑人巨大跨种族video_黑人巨大无码中文字幕无码_黑人巨茎大战俄罗斯美女_黑人巨茎大战俄罗斯美女,中文字幕av不卡|亚洲欧美国产另类|天天干在线播放|日韩黄视频|欧美七区|可以免费看毛片的网站|黄色片在线|国产精品96久久久久久

1. Jin J#*, Tang Y#, Hu C, Jiang LM, Jiang J, Li N, Liu WY, Chen SL, Li H, Lu NN, Cai Y, Li YH, Zhu Y, Cheng GH, Zhang HY, Wang X, Zhu SY, Wang J, Li GF, Yang JL, Zhang K, Chi Y, Yang L, Zhang HZ, Zhou ZX, Zhou AP, Zou SM, Fang H, Wang SL, Zhang HZ*, Wang XS*, Wei LC*, Wang WL*, Liu SX*, Gao YH*, Li YX*. Multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR). J Clin Oncol. 2022, 40:1681-1692. (IF=50.717, PIII)

2. Chen B#, Wu JX#, Cheng SH, Wang LM, Rong WQ,Wu F, Wang SL, Jin J, Liu YP, Song YW, Ren H, Fang H, Tang Y, Li N, Li YX*, Wang WH*. Phase 2 study of adjuvant radiotherapy following narrow-margin hepatectomy in patients with hepatocellular carcinoma. Hepatol. 2021, 74(5):2595-2604. (IF=17.298)

3. Wang SL# Fang F#, Hu C, Song YW, Wang WH, Jin J, Liu YP, Ren H, Liu J, Li GF, Du XH, Hui X, Tang Y, Jing H, Ma YC, Huang Z, Chen B, Tang Y, Li N, Lu NN, Qi SN, Yang Y, Sun GY, Liu XF, Li YX*. Hypofractionated versus conventional fractionated radiotherapy after breast-conserving surgery in the modern treatment era: a multicentre randomized controlled trial from China. J Clin Oncol. 2020, 38:3604-3614. (IF=44.544, PIII, R)

4. Wang SL#, Fang H#, Song YW, Wang WH, Hu C, Liu YP, Jin J, Liu XF, Yu ZH, Ren H, Li N, Lu NN, Tang Y, Tang Y, Qi SN, Sun GY, Peng R, Li S, Chen B, Yang Y, Li YX*. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for high-risk breast cancer patients: a randomised, non-inferiority, open-label, phase 3 trial. Lancet Oncol. 2019, 20:352-360. (IF=32.277, PIII, ESI, R)

5. Yang Y#, Cao JZ#, Lan SM, Wu JX, Wu T, Zhu SY, Qian LT, Hou XR, Zhang FQ, Zhang YJ, Zhu Y, Xu LM, Yuan ZY, Qi SN, and Li YX*. Association of improved locoregional control with prolonged survival in early-stage extranodal nasal-type NK/T-cell lymphoma. JAMA Oncol. 2017, 3(1):83-91. (IF=16.559)

6. Yang Y#, Zhu Y#, Cao JZ, Zhang YJ, Xu LM, Yuan ZY, Wu JX, Wang W, Wu T, Lu B, Zhu SY, Qian LT, Zhang FQ, Hou XR, and Li YX*. Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study. Blood. 2015, 126(12):1424-1432. (IF=9.762)

7. Wang ZY#, Liu QF, Wang H, Jin J, Wang WH, Wang SL, Song YW, Liu YP, Fang H, Ren H, Wu RY, Chen B, Zhang XM, Lu NN, Zhou LQ, Li YX*. Clinical implications of plasma Epstein-Barr virus DNA in early-stage extra nodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapy. Blood. 2012, 120(10):2003-2010. (IF=10.337)

8. Wang ZY#, Li YX*, Wang WH, Jin J, Wang H, Song YW, Liu QF, Wang SL, Liu YP, Qi SN, Fang H, Liu XF, and Yu ZH. Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents. Blood. 2009, 114(23):4771-4776. (IF=10.566, R)

9. Li YX*#, Fang H, Liu QF, Lu J, Qi SN, Wang H, Jin J, Wang WH, Liu YP, Song YW, Wang SL, Liu XF, Feng XL, and Yu ZH. Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring. Blood. 2008, 112(8):3057-3064. (IF=10.466, R)

10. Li YX*#, Yao B, Jin J, Wang WH, Liu YP, Song YW, Wang SL, Liu XF, Zhou LQ, He XH, Lu N, and Yu ZH. Radiotherapy as primary treatment for stage IE and IIE nasal NK/T-cell lymphoma. J Clin Oncol. 2006, 24(1):181-189. (IF=10.863, C100, R)